经动脉化疗栓塞后存活肝细胞癌基于MRI的影像学与影像组学模式的动态变化
本研究回顾性分析三个中心及一项临床试验中肝细胞癌患者初次经动脉化疗栓塞后的MRI资料,采用LI-RADS治疗反应算法v2024评估术后1个月和6个月存活肿瘤,比较基线与术后1个月、术后1个月与6个月之间的影像学和影像组学特征变化。结果显示存活肿瘤在术后1个月较基线出现T1WI信号升高、T2WI信号降低、廓清特征减少、体积缩小及ADC值升高等显著变化,部分影像组学特征亦发生显著改变。
要点
- TACE后1个月存活HCC较基线T1WI信号更高、T2WI信号更低、廓清特征更少、体积更小、ADC值更高。
- 存活肿瘤术后1个月较术后6个月DWI信号和ADC值均显著降低。
- 基线至术后1个月有82个(45.1%)影像组学特征发生显著变化。
核心结论
- 与基线相比,TACE后存活HCC在术后1个月和6个月随访中表现出一系列影像学和影像组学特征的显著变化。
研究设计与样本
- 回顾性分析,纳入2015年2月至2022年10月三个中心及一项临床试验(NCT03113955)中接受初次TACE的HCC患者,共160个存活肿瘤,采用LI-RADS治疗反应算法v2024评估术后1个月和6个月存活状态。
关键影像表现/征象
- 术后1个月存活肿瘤较基线T1WI信号强度更高(P=.024)、T2WI信号强度更低(P=.005)、廓清特征更少(P<.001)、体积更小(P<.001)、ADC值更高(P<.001)。
- 术后1个月存活肿瘤较术后6个月DWI信号强度显著降低(P=.002)、ADC值显著降低(P<.001)。
- 基线至术后1个月有82个(45.1%)影像组学特征发生显著变化。
- 术后1个月至术后6个月仅3个影像组学特征在存活肿瘤间差异有统计学意义。
诊断标准与关键数值
- 采用LI-RADS治疗反应算法v2024评估TACE后残留HCC的存活状态。
- 影像学和影像组学特征比较采用Wilcoxon符号秩检验和McNemar检验。
临床应用与阅片要点
- 临床用影像学方法诊断存活HCC具有挑战性,综合分析这些影像特征有助于准确识别存活肿瘤。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aims to analyze the magnetic resonance imaging (MRI) change patterns of viable hepatocellular carcinomas (HCCs) following the initial transarterial chemoembolization (TACE).
METHODS: A retrospective analysis of HCC patients' initial TACE from February 2015 to October 2022 across three centers and a clinical trial (NCT03113955) was conducted. The viability of residual HCCs at one and six months after TACE was evaluated using the LI-RADS Treatment Response Algorithm (LR-TRA) v2024. The radiological and radiomics features of post-TACE viable tumors between baseline and one-month, and between one- and six- months were compared using Wilcoxon signed-rank test and McNemar's test.
RESULTS: A total of 160 viable tumors were included in the study. Viable tumors at one month after TACE exhibited higher T1WI intensity (P =.024), lower T2WI intensity (P =.005), fewer washout features (P <.001), smaller size (P <.001), and higher ADC values (P <.001) compared to baseline HCC imaging.A significant reduction in DWI intensity (P =.002) and ADC values (P <.001) were observed in viable tumors at one month compared to those at six months. There were 82 (45.1%) radiomics features that changed significantly between the baseline and one-month. Only three radiomics features showed statistically significant difference of viable tumors between one- and six-month.
CONCLUSIONS: Compared to the baseline, viable HCCs after TACE demonstrated significant changes of imaging characteristics in a series of radiological and radiomics features at one- and six-month follow-ups.
CLINICAL RELEVANCE STATEMENT: Clinically diagnosing of viable HCCs using radiological methods is challenging. A comprehensive analysis of these imaging characteristics can facilitate the accurate identification of viable tumors.
引用
- Wang W, Zhang S, Zhong B, et al. Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization. Abdom Radiol (NY). 2024. PMID: 39542948. doi:10.1007/s00261-024-04676-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。